Cubist Pharmaceuticals is a bio-pharmaceutical company focused on the research, commercial­ization and creation of pharmaceutical products that address unmet medical needs in the acute care environment.

Product Pipeline

CXA-201 (ceftolozane/tazobactam)

Gram-negative CXA-201

for cUTI (complicated urinary tract infection)

CXA-201 (ceftolozane/tazobactam), which is being developed as a first-line intravenous therapy for the treatment of certain serious Gram-negative bacterial infections, including those caused by multi-drug resistant Pseudomonas aeruginosa, advanced into Phase 3 trials in July 2011…

Cubicin
Entereg
Dificid

Upcoming Events

News & Press

19 Jan

Cubist Pharmaceuticals Reports 2011 Fourth Quarter and Full Year Financial Results

— Q4 Total Net Revenues of $213 million, Up 32% Over Q4 2010
— Full Year Total Net Revenues of $754 million, Up 18% Over Previous Year
— Full Year Non-GAAP Diluted Net Income of $2.70 Per Share
— Full Year GAAP Diluted Net Income of $0.52 Per Share

LEXINGTON, Mass. -- Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced results for the fourth quarter and year ended December 31, 2011. The Company will host a conference call and webcast today at 5:00 p.m. ET to discuss these results and other business updates (details below).

Careers at Cubist

Hernando

Meet Hernando

Senior Medical Director, Clinical Research

Q: What are your basic job responsibilities? Hernando: I am a senior medical director working in clinical research at Cubist,…

Current Opportunities

View our Careers page to see all current opportunities with Cubist.

Community Outreach

Steve Gillman and Sean Muller

Cubist Selects Science Education Award Winner

Cubist, in partnership with the New England Patriots Radio Network, 98.5 The Sports Hub, has selected Sean Muller, a science teacher at Merrimack High School, in Merrimack, New Hampshire, to receive the Cubist Pharmaceuticals Science Education Leadership Award.

Investor Center

Cubist Pharmaceuticals $41.61 -0.07
CBST (NASDAQ) UPD: 4:00 pm

Investor Resources

Context
-------

$_SERVER: Array
(
    [HTTP_HOST] => www.cubist.com
    [HTTP_ACCEPT] => text/html,application/xhtml+xml,text/xml;q=0.9,text/plain;q=0.8,image/png,*/*;q=0.5
    [HTTP_ACCEPT_CHARSET] => ISO-8859-1,utf-8;q=0.7,*;q=0.7
    [HTTP_ACCEPT_ENCODING] => gzip
    [HTTP_ACCEPT_LANGUAGE] => en-us,en;q=0.5
    [HTTP_CACHE_CONTROL] => no-cache
    [HTTP_COOKIE] => WT_COOKIE=10.91.35.89.1328330998274210
    [HTTP_IF_MODIFIED_SINCE] => Sat, 25 Sep 2010 09:32:13 GMT
    [HTTP_PRAGMA] => no-cache
    [HTTP_USER_AGENT] => CCBot/1.0 (+http://www.commoncrawl.org/bot.html)
    [HTTP_X_CC_ID] => ccc01-01
    [HTTP_X_FORWARDED_FOR] => 38.107.179.210
    [HTTP_X_FORWARDED_PORT] => 80
    [HTTP_X_FORWARDED_PROTO] => http
    [HTTP_CONNECTION] => keep-alive
    [PATH] => /sbin:/usr/sbin:/bin:/usr/bin
    [SERVER_SIGNATURE] => <address>Apache/2.2.10 (Fedora) Server at www.cubist.com Port 80</address>
  
    [SERVER_SOFTWARE] => Apache/2.2.10 (Fedora)
    [SERVER_NAME] => www.cubist.com
    [SERVER_ADDR] => 10.126.43.25
    [SERVER_PORT] => 80
    [REMOTE_ADDR] => 10.91.35.89
    [DOCUMENT_ROOT] => /var/www/cubist.com.2010
    [SERVER_ADMIN] => comops@cubist.com
    [SCRIPT_FILENAME] => /var/www/cubist.com.2010/index.php
    [REMOTE_PORT] => 30131
    [GATEWAY_INTERFACE] => CGI/1.1
    [SERVER_PROTOCOL] => HTTP/1.1
    [REQUEST_METHOD] => GET
    [QUERY_STRING] => {empty_string}
    [REQUEST_URI] => /index.php
    [SCRIPT_NAME] => /index.php
    [PHP_SELF] => /index.php
    [REQUEST_TIME] => 1328331036
)

$_POST: Array
(
)

$_GET: Array
(
)

$_FILES: Array
(
)

$_SESSION: Array
(
    [fSession::type] => normal
    [fSession::expires] => 1328332476
)

$_COOKIE: Array
(
    [WT_COOKIE] => 10.91.35.89.1328330998274210
)
Warning
-------
[internal function]
Unknown: write failed: No space left on device (28)
Warning
-------
[internal function]
Unknown: Failed to write session data (files). Please verify that the current setting of session.save_path is correct (/var/tmp/)